Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_assertion type Assertion NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_head.
- NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_assertion wasGeneratedBy ECO_0000203 NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_provenance.
- NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_assertion wasDerivedFrom befree-20150227 NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_provenance.
- NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_assertion SIO_000772 23627936 NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_provenance.
- NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_assertion evidence source_evidence_literature NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_provenance.
- NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_assertion description "[Nutlin-3 has been proposed as an anti-neoplastic agent for the treatment of onco-hematological diseases characterized by a lower incidence of p53 mutation with respect to solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752609.RAZS9vGQaFQIg1c52ipUVHiK_G1rmysf5rpCD2XCqbAe0130_provenance.